共 113 条
[1]
Dy GW(2017)Global burden of urologic cancers, 1990-2013 Eur Urol 71 437-446
[2]
Gore JL(2019)Increasing kidney cancer incidence and survival in Estonia: role of age and stage Acta Oncol 58 21-28
[3]
Forouzanfar MH(2009)Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma J Clinical Oncol 27 3584-3590
[4]
Naghavi M(2013)Pazopanib versus sunitinib in metastatic renal-cell carcinoma N Engl J Med 369 722-731
[5]
Fitzmaurice C(2007)Sorafenib in advanced clear-cell renal-cell carcinoma N Engl J Med 356 125-134
[6]
Innos K(2002)Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma J Clin Oncol 20 289-296
[7]
Sepp T(2010)Phase III trial of bevacizumab plus interferon alfa-2a in patients with metastatic renal cell carcinoma (AVOREN): final analysis of overall survival J Clin Oncol 28 2144-2150
[8]
Baburin A(2007)Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma N Engl J Med 356 2271-2281
[9]
Kotsar A(2010)Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial J Clin Oncol 28 1061-1068
[10]
Lang K(2011)Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial Lancet 378 1931-1939